16 For example, pegaspargase, a drug initially approved in 1994 by the FDA for treatment of leukemia, was only in shortage in Germany but not in the US. The price for this drug was substantially lower ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...

Blueprint Medicines' AYVAKIT leads its revenue growth, while its pipeline targets multiple cancers. Read why BPMC stock is a ...

JP Morgan Chase analysts say they’re ‘not surprised’ sector has come ‘under pressure’ since Kennedy’s nomination ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

President-elect Donald Trump is not shy about his enjoyment of McDonald’s — and his choice to run America’s health apparatus is not shy about critiquing his future boss’ diet. “The stuff that he eats ...

President-elect Donald Trump has announced plans to appoint Robert F. Kennedy Jr. as head of the U.S. Department of Health ...

German Chancellor Olaf Scholz, mired in a political crisis, said Friday he is open to discussions on whether to move forward snap elections he has said he expects by March.

The origins of autoimmune diseases like it are often mysterious, and an immune system that sees the body it inhabits as an ...

Though we’ve recently observed some improvement in U.S. biosimilar penetration, market entry and uptake still consistently ...

The FDA, which usually adheres to the recommendations ... the holder of Zynquista’s marketing rights in the region, Guidehouse Germany GmbH, withdrew (PDF) the marketing authorization, saying ...